Rating:
Sell PARD
42.30 %
Poniard Pharmaecuticals, Inc. (PARD) downgraded to Sell with price target $1 by Canaccord Adams
Canaccord Adams rated Sell Poniard Pharmaecuticals, Inc. (NASDAQ: PARD) on 01/25/2010, when the stock price was $2.22.
Since then, Poniard Pharmaecuticals, Inc. has lost 29.73% as of 03/19/2010's recent price of $1.56. If you would have followed this Canaccord Adams's recommendation on PARD, you would have gained 42.3% of your investment.